Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)

NCT01416636 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-operable Chronic Thromboembolic Pulmonary Hypertension

Interventions

DRUG: Treprostinil sodium

Sponsor

SciPharm SàRL